Combination Treatment of PDS0101 and Pembrolizumab

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaNCT06790966PDSBPhase 3Terminated2026-08-25Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.